Evolution Research Group | Clinical Pharmacology of Miami
Site insights
Top conditions
Top treatments
Parent organization
This site is a part of Evolution Research Group
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants
This is a single-center, open-label, randomized, single-dose, parallel, Phase 1, 4-arm study designed to determine the bioequivalence and investigate...
The principal aim of this study is to obtain safety and tolerability data when MRT-8102 is administered orally as single and multiple doses to health...
The main purpose of this study is to evaluate how much lepodisiran gets into the blood stream and how long it takes the body to get rid of it when gi...
This is a 4-part study that includes a Part A, Part B, Part C, and Part D. Parts A and D will study the safety and tolerability of the study drug kno...
The purpose of this study is to compare the plasma pharmacokinetics (PK) of nemabrutinib (MK-1026) following a single oral dose of nemtabrutinib in p...
This is a Phase 3, randomized, double-blind, comparator- and placebo-controlled study to evaluate analgesic efficacy and safety of TLC590 via local i...
This study is to assess how oral emraclidine moves through the body of healthy elderly adult participants, and assess adverse events, and tolerabilit...
Researchers have designed a study medicine called opevesostat as a new way to treat prostate cancer.The purpose of this study is to learn what happen...
The main objective of this trial is to evaluate the pharmacokinetics (PK) of maridebart cafraglutide administered as a single dose using two differen...
This study will evaluate and compare the PK in subjects with severe HI to that of matched healthy control subjects with normal hepatic function.
The main purpose of this study is to compare the bioavailability of 3 different formulations of LY4100511 and if the use of a proton pump inhibitor (...
The purposes of this study are to determine:* The pharmacokinetics (the amount of study drug in your blood and how long it takes the body to get rid...
This is a First in Human study to evaluate the safety and tolerability of DA-1726 following single and multiple doses in participants with obesity, b...
The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.
Trial sponsors
Clinical trials
Research sites
Resources
Legal